Literature DB >> 25403724

Disrupted functional and structural networks in cognitively normal elderly subjects with the APOE ɛ4 allele.

Yaojing Chen1, Kewei Chen2, Junying Zhang1, Xin Li1, Ni Shu1, Jun Wang1, Zhanjun Zhang1, Eric M Reiman3.   

Abstract

As the Apolipoprotein E (APOE) ɛ4 allele is a major genetic risk factor for sporadic Alzheimer's disease (AD), which has been suggested as a disconnection syndrome manifested by the disruption of white matter (WM) integrity and functional connectivity (FC), elucidating the subtle brain structural and functional network changes in cognitively normal ɛ4 carriers is essential for identifying sensitive neuroimaging based biomarkers and understanding the preclinical AD-related abnormality development. We first constructed functional network on the basis of resting-state functional magnetic resonance imaging and a structural network on the basis of diffusion tensor image. Using global, local and nodal efficiencies of these two networks, we then examined (i) the differences of functional and WM structural network between cognitively normal ɛ4 carriers and non-carriers simultaneously, (ii) the sensitivity of these indices as biomarkers, and (iii) their relationship to behavior measurements, as well as to cholesterol level. For ɛ4 carriers, we found reduced global efficiency significantly in WM and marginally in FC, regional FC dysfunctions mainly in medial temporal areas, and more widespread for WM network. Importantly, the right parahippocampal gyrus (PHG.R) was the only region with simultaneous functional and structural damage, and the nodal efficiency of PHG.R in WM network mediates the APOE ɛ4 effect on memory function. Finally, the cholesterol level correlated with WM network differently than with the functional network in ɛ4 carriers. Our results demonstrated ɛ4-specific abnormal structural and functional patterns, which may potentially serve as biomarkers for early detection before the onset of the disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25403724      PMCID: PMC4367462          DOI: 10.1038/npp.2014.302

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  57 in total

1.  Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain.

Authors:  Susan M Resnick; Dzung L Pham; Michael A Kraut; Alan B Zonderman; Christos Davatzikos
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

2.  Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice.

Authors:  H Hamanaka; Y Katoh-Fukui; K Suzuki; M Kobayashi; R Suzuki; Y Motegi; Y Nakahara; A Takeshita; M Kawai; K Ishiguro; M Yokoyama; S C Fujita
Journal:  Hum Mol Genet       Date:  2000-02-12       Impact factor: 6.150

Review 3.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

4.  APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42.

Authors:  Yvette I Sheline; John C Morris; Abraham Z Snyder; Joseph L Price; Zhizi Yan; Gina D'Angelo; Collin Liu; Sachin Dixit; Tammie Benzinger; Anne Fagan; Alison Goate; Mark A Mintun
Journal:  J Neurosci       Date:  2010-12-15       Impact factor: 6.167

5.  Disrupted topological organization in white matter structural networks in amnestic mild cognitive impairment: relationship to subtype.

Authors:  Ni Shu; Ying Liang; He Li; Junying Zhang; Xin Li; Liang Wang; Yong He; Yongyan Wang; Zhanjun Zhang
Journal:  Radiology       Date:  2012-09-14       Impact factor: 11.105

6.  Abnormal connectivity in the posterior cingulate and hippocampus in early Alzheimer's disease and mild cognitive impairment.

Authors:  Yongxia Zhou; John H Dougherty; Karl F Hubner; Bing Bai; Rex L Cannon; R Kent Hutson
Journal:  Alzheimers Dement       Date:  2008-07       Impact factor: 21.566

7.  Protein synthesis and neurotrophin-dependent structural plasticity of single dendritic spines.

Authors:  Jun-Ichi Tanaka; Yoshihiro Horiike; Masanori Matsuzaki; Takashi Miyazaki; Graham C R Ellis-Davies; Haruo Kasai
Journal:  Science       Date:  2008-02-28       Impact factor: 47.728

8.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

9.  A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier.

Authors:  B Dehouck; L Fenart; M P Dehouck; A Pierce; G Torpier; R Cecchelli
Journal:  J Cell Biol       Date:  1997-08-25       Impact factor: 10.539

10.  Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates.

Authors:  Kewei Chen; Eric M Reiman; Gene E Alexander; Richard J Caselli; Richard Gerkin; Daniel Bandy; Alisa Domb; David Osborne; Nick Fox; William R Crum; Ann M Saunders; John Hardy
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

View more
  21 in total

1.  Disrupted topology of the resting state structural connectome in middle-aged APOE ε4 carriers.

Authors:  L E Korthauer; L Zhan; O Ajilore; A Leow; I Driscoll
Journal:  Neuroimage       Date:  2018-05-24       Impact factor: 6.556

2.  APOE*E4 Is Associated with Gray Matter Loss in the Posterior Cingulate Cortex in Healthy Elderly Controls Subsequently Developing Subtle Cognitive Decline.

Authors:  S Haller; M-L Montandon; C Rodriguez; M Ackermann; F R Herrmann; P Giannakopoulos
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-11       Impact factor: 3.825

3.  Precuneus degeneration in nondemented elderly individuals with APOE ɛ4: Evidence from structural and functional MRI analyses.

Authors:  Yaojing Chen; Zhen Liu; Junying Zhang; Kewei Chen; Li Yao; Xin Li; Gaolang Gong; Jun Wang; Zhanjun Zhang
Journal:  Hum Brain Mapp       Date:  2016-09-04       Impact factor: 5.038

Review 4.  Revolution of Resting-State Functional Neuroimaging Genetics in Alzheimer's Disease.

Authors:  Patrizia A Chiesa; Enrica Cavedo; Simone Lista; Paul M Thompson; Harald Hampel
Journal:  Trends Neurosci       Date:  2017-07-03       Impact factor: 13.837

Review 5.  ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease.

Authors:  Courtney Lane-Donovan; Joachim Herz
Journal:  Trends Endocrinol Metab       Date:  2017-01-02       Impact factor: 12.015

6.  Liver X receptors regulate cerebrospinal fluid production.

Authors:  Y-B Dai; W-F Wu; B Huang; Y-F Miao; S Nadarshina; M Warner; J-Å Gustafsson
Journal:  Mol Psychiatry       Date:  2015-09-01       Impact factor: 15.992

7.  The Structural and Functional Connectome and Prediction of Risk for Cognitive Impairment in Older Adults.

Authors:  Joey A Contreras; Joaquín Goñi; Shannon L Risacher; Olaf Sporns; Andrew J Saykin
Journal:  Curr Behav Neurosci Rep       Date:  2015-10-29

8.  Alterations in structural rich-club connectivity of the precuneus are associated with depressive symptoms among individuals with subjective memory complaints.

Authors:  Geon Ha Kim; Jung Yoon Kim; Jieun E Kim; Jiyoung Ma; Bori R Kim; Jooyeon Jamie Im; Hyeonseok S Jeong; Eun Namgung; Suji Lee; Ilhyang Kang; In Kyoon Lyoo; Jaeuk Hwang; Sujung Yoon
Journal:  Cogn Affect Behav Neurosci       Date:  2019-02       Impact factor: 3.282

9.  Learning Common Harmonic Waves on Stiefel Manifold - A New Mathematical Approach for Brain Network Analyses.

Authors:  Jiazhou Chen; Guoqiang Han; Hongmin Cai; Defu Yang; Paul J Laurienti; Martin Styner; Guorong Wu
Journal:  IEEE Trans Med Imaging       Date:  2020-12-29       Impact factor: 10.048

Review 10.  The human connectome in Alzheimer disease - relationship to biomarkers and genetics.

Authors:  Meichen Yu; Olaf Sporns; Andrew J Saykin
Journal:  Nat Rev Neurol       Date:  2021-07-20       Impact factor: 44.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.